Editor’s notes

Monday's gap list had a $1.17 billion AI-infrastructure contract at a penny stock, a Phase 3 readout in eye disease and a cash takeover. Of the 10 largest opening gaps, 7 closed below their opening price and 3 held at or above it. None gave back the whole gap.

Market context: Major US indexes fell on the day; the S&P 500 and Nasdaq both declined as oil prices rose (TheStreet session recap).

By the numbers: Under FennEdge's default filters (US common stock or ADR, full-day volume ≥ 1M), 12 stocks opened at least 20% above their prior close.

The list is ranked by opening gap, not market cap.

Notable tickers

SOAR — Volato Group

• Catalyst: an 8-K says Volato's Alignment Engine subsidiary signed a master services agreement with a customer for dedicated AMD GPU clusters at its Ohio campus.
  • The two initial orders have 48-month terms, starting December 31, 2026 and June 30, 2027.
  • Their aggregate contract value is about $1.17 billion.
  • Press release: Business Wire.
• SEC filings:
  • 8-K, Sep 28 (Items 1.01, 7.01).
  • Earlier in September, an 8-K on Sep 11 reported Items 2.01, 3.02 and 3.03, among others.
• Price action:
  • Opened at $0.3788, more than double the $0.1795 prior close.
  • The extended-session high of $0.4682 printed at 10:21 ET.
  • Closed at $0.3188: below the open, +77.6% on the day (partial fade).
• Shares:
  • The 10-Q cover reported 53,633,248 shares outstanding as of Aug 3, 2026 (10-Q).
  • Day volume was about 999.8 million shares, roughly 18.6 times that count.
• Links: SOAR stock page

KOD — Kodiak Sciences

• Catalyst: Kodiak said both tarcocimab tedromer and tabirafusp-ted (KSI-501) met their primary endpoints in the Phase 3 DAYBREAK study in wet age-related macular degeneration (press release, Exhibit 99.1).
• SEC filings:
  • 8-K, Sep 28 (Item 8.01).
  • Form 4s and a Schedule 13D/A followed on Sep 29–30.
• Price action:
  • The only top-three name that closed above its open: opened at $61.705 and closed at $89.92, +178.0% from the $32.35 prior close.
  • The extended-session high of $95.77 printed late, at 15:44 ET.
• Shares: 62,849,457 outstanding as of Aug 6, 2026 (10-Q).
• Links: KOD stock page

CLRO — ClearOne

• Catalyst: we found no ClearOne press release dated Sep 28.
  • ClearOne has a pending merger with Cortigent, a Vivani Medical subsidiary; the agreement was signed July 1, 2026.
  • On Sep 16, Vivani said it expected the deal to close in October, alongside a financing (Investing.com).
• SEC filings: S-1/A, Sep 4. We found no 8-K between Sep 1 and Oct 4.
• Price action:
  • The extended-session high of $7.2997 printed in premarket at 04:24 ET.
  • Opened at $5.83 and closed at $5.10 (partial fade, +47.8% on the day).
• Shares:
  • 2,675,412 outstanding as of Aug 14, 2026 (10-Q).
  • Volume of 28.3 million was about 10.6 times that count.
• Links: CLRO stock page

LFCR — Lifecore Biomedical

• Catalyst: Lifecore agreed to be acquired by affiliates of Webster Equity Partners for $6.28 per share in cash plus one contingent value right (CVR) per share (8-K, Sep 28, Items 1.01, 7.01).
• SEC filings: the 8-K above; DEFA14A and Schedule 13D/A filings on Sep 28–29; a second 8-K (Item 1.01) on Sep 29.
• Price action:
  • Opened and closed at $6.52, above the $6.28 cash component. The filing sets out the CVR terms.
  • The extended-session high of $6.65 printed after the close, at 16:08 ET.
• Shares: 37,853,060 outstanding as of Jul 29, 2026 (10-Q).
• Links: LFCR stock page

Terms used in these notes

• High-of-day times are the first 1-minute bar at the 04:00–20:00 ET high.
• Close vs open:
  • Held = close ≥ open.
  • Partial fade = previous close ≤ close < open.
  • Gave back gap = close < previous close.
• Shares outstanding come from SEC cover pages on the date stated and may have changed since.